PAVM PAVmed Inc
Price (delayed)
$1.72
Market cap
$17.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.17
Enterprise value
$42.43M
PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital
Highlights
PAVM's gross margin has surged by 89% year-on-year and by 38% since the previous quarter
PAVM's gross profit is up by 46% year-on-year and by 22% since the previous quarter
PAVM's quick ratio is down by 34% year-on-year but it is up by 2.1% since the previous quarter
The equity has dropped by 135% year-on-year and by 8% since the previous quarter
The debt has grown by 3.9% YoY
Key stats
What are the main financial stats of PAVM
Market
Valuations
Earnings
Shares outstanding
10.41M
Market cap
$17.9M
Enterprise value
$42.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
4.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.08
Revenue
$3.83M
EBIT
-$57.54M
EBITDA
-$55.07M
Free cash flow
-$47.97M
Per share
Balance sheet
Liquidity
EPS
-$8.17
Free cash flow per share
-$5.24
Book value per share
-$7.84
Revenue per share
$0.42
TBVPS
$4.2
Total assets
$39.41M
Total liabilities
$58.06M
Debt
$50.03M
Equity
-$73.95M
Working capital
-$23.18M
Debt to equity
-0.68
Current ratio
0.57
Quick ratio
0.48
Net debt/EBITDA
-0.45
Margins
Efficiency
Dividend
EBITDA margin
-1,438.3%
Gross margin
-77.6%
Net margin
-1,508.1%
Operating margin
-1,557.4%
Return on assets
-177.5%
Return on equity
N/A
Return on invested capital
-751.2%
Return on capital employed
N/A
Return on sales
-1,502.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PAVM stock price
How has the PAVmed stock price performed over time
Intraday
8.86%
1 week
48.28%
1 month
115%
1 year
-70.5%
YTD
-58.25%
QTD
111.04%
Financial performance
How have PAVmed's revenue and profit performed over time
Revenue
$3.83M
Gross profit
-$2.97M
Operating income
-$59.63M
Net income
-$57.75M
Gross margin
-77.6%
Net margin
-1,508.1%
PAVM's gross margin has surged by 89% year-on-year and by 38% since the previous quarter
The net margin has soared by 85% YoY and by 26% from the previous quarter
The operating margin has surged by 85% year-on-year and by 25% since the previous quarter
PAVM's gross profit is up by 46% year-on-year and by 22% since the previous quarter
Growth
What is PAVmed's growth rate over time
Valuation
What is PAVmed stock price valuation
P/E
N/A
P/B
N/A
P/S
4.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.08
The EPS is up by 35% year-on-year and by 10% since the previous quarter
The equity has dropped by 135% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 64% less than its last 4 quarters average of 10.5
PAVmed's revenue has increased by 27% from the previous quarter
Efficiency
How efficient is PAVmed business performance
The ROS has soared by 85% year-on-year and by 26% since the previous quarter
PAVM's return on assets is down by 37% year-on-year and by 3.7% since the previous quarter
The company's return on invested capital rose by 8% YoY
Dividends
What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PAVM.
Financial health
How did PAVmed financials performed over time
The total assets is 32% less than the total liabilities
PAVM's quick ratio is down by 34% year-on-year but it is up by 2.1% since the previous quarter
PAVmed's current ratio has decreased by 33% YoY but it has increased by 6% QoQ
The debt is 168% more than the equity
The equity has dropped by 135% year-on-year and by 8% since the previous quarter
PAVM's debt to equity has surged by 56% year-on-year and by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.